Safety study of the monoclonal antibody teplizum-ab (MGA031) in subjects with moderate or more severe psoriasis.

Journal of Drugs in Dermatology › Vol. 9 Nbr. 1, January 2010

Position:: PSORIASIS - Brief article

Linked as:

< Previous

Next >

Summary

PSORIASIS - Brief article

See the full content of this document

Extract

Safety study of the monoclonal antibody teplizum-ab (MGA031) in subjects with moderate or more severe psoriasis.

Sponsored by MacroGenics; Eli Lilly and Company. ...

See the full content of this document

Sponsored links

< Previous

Next >

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Twentieth Century Mythologies Rev Ed. | Digital Tv? No Thanks | Anti-Tobacco Events Planned at Maine Schools | Name Changes in 19th Century Went Through Maine Legislature | decisión nº pj00820100000028 de tribunal octavo de primera instancia de sustanciación, mediación y ejecución del trabajo de carabobo (extensión valencia), ... | Decisión de Juzgado Tercero de Primera Instancia en lo Civil Mercantil Agrario y Tránsito de Anzoategui Extensión Barcelona de October 13 200... | decisión nº 15c-11.352-07 de tribunal décimo quinto de control de caracas de december 20 20... | Decisión nº PJ0572007000031 de Tribunal Superior Primero del Trabajo de Carabobo, de Februar...